Journal of Clinical Endocrinology & Metabolism, Vol 66, 367-375, Copyright © 1988 by Endocrine Society

ARTICLES

Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies

A Lucas-Martin, M Foz-Sala, I Todd, GF Bottazzo and R Pujol-Borrell
Department of Medicine, Hospital General Valle de Hebron, Barcelona, Spain.

The proteins of the major histocompatibility system (HLA in humans) play an essential role in the regulation of immune responses due to their involvement in the presentation of antigen to T lymphocytes. Thyroid follicular cells (thyrocytes) from patients with Graves' disease and Hashimoto's thyroiditis demonstrate increased expression of HLA class I and aberrantly or inappropriately express class II antigens, a phenomenon that may play an important role in the pathogenesis of these autoimmune diseases. To establish if these changes in the expression of HLA molecules are characteristic of thyroid autoimmune disease, the immunopathological features (including class I and class II antigen expression) of 100 thyroidectomy specimens from patients with nonautoimmune thyroid disease were studied by indirect immunofluorescence, and the results compared with the findings in specimens from 14 patients with Graves' disease and 12 subjects undergoing laryngectomies for carcinoma. Increased class I product expression was found in 61% of all tissues studied, with maximal occurrence in papillary carcinomas (100%) and Graves' disease (86%), but it was also detected in 50% of the glands containing nodular lesions and in 16% of the control glands. Inappropriate class II molecule expression was found in Graves' disease (71%), hyperplastic nodules (53%), multinodular glands (44%), papillary carcinomas (38%), and 16% of the control glands. In summary, an increase in inappropriate HLA class I and class II expression was very common in nonautoimmune thyroid glands, but it generally occurred in the context of lymphocytic infiltration and thyroid autoantibodies (i.e. focal thyroiditis). Multiple correlation analyses of these 4 phenomena indicated heterogeneity in the mechanism leading to the inappropriate expression of thyrocyte class II antigens in the different conditions studied.

This article has been cited by other articles:

				L. Muixi, M. Carrascal, I. Alvarez, X. Daura, M. Marti, M. P. Armengol, C. Pinilla, J. Abian, R. Pujol-Borrell, and D. Jaraquemada Thyroglobulin Peptides Associate In Vivo to HLA-DR in Autoimmune Thyroid Glands J. Immunol., July 1, 2008; 181(1): 795 - 807. [Abstract] [Full Text] [PDF]

				J. Modi, A. Patel, R. Terrell, R. M. Tuttle, and G. L. Francis Papillary Thyroid Carcinomas from Young Adults and Children Contain a Mixture of Lymphocytes J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4418 - 4425. [Abstract] [Full Text] [PDF]

				M. P. Armengol, M. Juan, A. Lucas-Martin, M. T. Fernandez-Figueras, D. Jaraquemada, T. Gallart, and R. Pujol-Borrell Thyroid Autoimmune Disease : Demonstration of Thyroid Antigen-Specific B Cells and Recombination-Activating Gene Expression in Chemokine-Containing Active Intrathyroidal Germinal Centers Am. J. Pathol., September 1, 2001; 159(3): 861 - 873. [Abstract] [Full Text] [PDF]

				F. Schuppert, D. Ehrenthal, A. Frilling, K. Suzuki, G. Napolitano, and L. D. Kohn Increased Major Histocompatibility Complex (MHC) Expression in Nontoxic Goiters Is Associated with Iodide Depletion, Enhanced Ability of the Follicular Thyroglobulin to Increase MHC Gene Expression, and Thyroid Autoantibodies J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 858 - 867. [Abstract] [Full Text]

				Y. Ashhab, O. Dominguez, M. Sospedra, C. Roura-Mir, A. Lucas-Martín, and R. Pujol-Borrell A One-Tube Polymerase Chain Reaction Protocol Demonstrates CC Chemokine Overexpression in Graves' Disease Glands J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2873 - 2882. [Abstract] [Full Text]

				M. Catalfamo, L. Serradell, C. Roura-Mir, E. Kolkowski, M. Sospedra, M. Vives-Pi, F. Vargas-Nieto, R. Pujol-Borrell, and D. Jaraquemada HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules Int. Immunol., February 1, 1999; 11(2): 269 - 277. [Abstract] [Full Text] [PDF]

				K. Kawai, E. Resetkova, T. Enomoto, V. Fornasier, and R. Volpé Is Human Leukocyte Antigen-DR and Intercellular Adhesion Molecule-1 Expression on Human Thyrocytes Constitutive in Papillary Thyroid Cancer? Comparative Studies of Human Thyroid Xenografts in Severe Combined Immunodeficient and Nude Mice J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 157 - 164. [Abstract] [Full Text]

				A. Fiumara, A. Belfiore, G. Russo, E. Salomone, G. M. Santonocito, O. Ippolito, R. Vigneri, and P. Gangemi In Situ Evidence of Neoplastic Cell Phagocytosis by Macrophages in Papillary Thyroid Cancer J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1615 - 1620. [Abstract] [Full Text] [PDF]

				D. Kausman and D.A. Isenberg Role of the Biologics in Autoimmunity Lupus, December 1, 1994; 3(6): 461 - 466. [PDF]